Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Levofloxacin for uti?Amoxycillin and potassium clavulanate?Levothyroxine 125 mcg price?How much does sunosi cost without insurance?Ticagrelor 60 mg price?
See the DrugPatentWatch profile for Tyrvaya
Tyrvaya is available in a 0.7 mL single-dose nasal spray device [1]. Each box contains 12 such devices [1].
Tyrvaya is a prescription nasal spray that is used to treat the signs and symptoms of dry eye disease [1]. It works by activating the trigeminal nerve, which then stimulates natural tear production [1]. This stimulation leads to increased tear film secretion [1].
Tyrvaya is indicated for the treatment of the signs and symptoms of dry eye disease [1].
Information regarding the specific patent expiry for Tyrvaya is not publicly detailed in the provided text. However, DrugPatentWatch.com tracks patent information for pharmaceuticals, which may include Tyrvaya [2].
Oculis Pharma developed Tyrvaya, and it is manufactured by Horizon Therapeutics [1].
Other Questions About Tyrvaya :